🔎 Trials Near Me

Akèy › Ren polisistik otozomal dominan

Etid klinik pou Ren polisistik otozomal dominan ap rekrite nan Etazini

11 etid pou Ren polisistik otozomal dominan ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Bempedoic Acid Therapy for Polycystic Kidney Disease

Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Sep 29, 2026 · NCT07282821

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07228364

Managing Depressive Symptoms in ADPKD

Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Aug 7, 2026 · NCT07745920

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Ap rekriteEtid obsèvasyon
Jiska laj 18 · Tout sèks · Mizajou Jun 15, 2026 · NCT04338048

Early PKD Observational Cohort Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 4 a 35 · Tout sèks · Mizajou Apr 27, 2026 · NCT02936791

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT07454174

A Prospective Observational Study of Foam Sclerotherapy .

Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Jan 26, 2026 · NCT04111692

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 30 · Tout sèks · Mizajou Jan 16, 2026 · NCT04344769

NOX4 and Related Biomarkers in ADPKD

Ap rekriteEtid obsèvasyon
Laj 15 a 40 · Tout sèks · Mizajou Jan 9, 2026 · NCT04630613

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 6, 2025 · NCT06582875

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.